Circulating Tumour DNA guidEd Therapy for Stage IIB/C mElanoma After surgiCal resecTION

NCT04901988 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped Closed earlier than expected due to the need for a redesign to reflect the recent change in standard of care guidelines. New design will include these treatments.

Conditions

Melanoma (Skin)
Melanoma, Stage II

Interventions

DRUG: Nivolumab 10 MG/ML

Sponsor

The Christie NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]